| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 2 | +100.00% | +31.45% | +0.96% | +30.48% | +30.48% | — |
| 14d | 2 | +100.00% | +61.52% | +1.19% | +60.34% | +60.34% | — |
| 30d | 2 | +100.00% | +62.70% | +2.27% | +60.42% | +60.42% | — |
| 60d | 2 | +100.00% | +44.92% | +2.10% | +42.82% | +42.82% | — |
| 90d | 2 | +100.00% | +9.57% | +1.09% | +8.48% | +8.48% | — |
| 180d | 2 | +100.00% | +15.23% | — | — | — | — |
| 1y | 2(2 pending) | — | — | — | — | — | — |
| 2y | 2(2 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| VRCA VERRICA PHARMACEUTICALS INC. | PURCHASEGRANT Stock grant | 171,340 | — | — | 171,340 | Jun 5, 2026 | Jun 9, 2026 ↗ | View → |
| VRCA VERRICA PHARMACEUTICALS INC. | PURCHASE Chief Operating Officer | 10,000 | $4.24 | $42.4K | 21,000 | Nov 25, 2025 | Nov 25, 2025 ↗ | View → |
| VRCA VERRICA PHARMACEUTICALS INC. | PURCHASE Chief Operating Officer | 2,500 | — | — | 2,500 | Nov 25, 2025 | Nov 25, 2025 ↗ | View → |
| VRCA VERRICA PHARMACEUTICALS INC. | PURCHASEGRANT Stock grant | 950,000 | — | — | 950,000 | Dec 9, 2024 | Dec 9, 2024 ↗ | View → |